UroGen Pharma URGN Increase Decrease In Uncertain Tax Positions
Increase Decrease In Uncertain Tax Positions at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept urgn:IncreaseDecreaseInUncertainTaxPositions.
The official record: UroGen Pharma’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's increase decrease in uncertain tax positions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's increase decrease in uncertain tax positions?
- UroGen Pharma (URGN) reported increase decrease in uncertain tax positions of $28K in Q4 2025.
- How has UroGen Pharma's increase decrease in uncertain tax positions changed year-over-year?
- UroGen Pharma's increase decrease in uncertain tax positions decreased by 81.2% year-over-year, from $149.25K to $28K.
- What is the long-term trend for UroGen Pharma's increase decrease in uncertain tax positions?
- Over 4 years (2021 to 2025), UroGen Pharma's increase decrease in uncertain tax positions has grown at a -2.7% compound annual growth rate (CAGR), from $125K to $112K.
- What does increase decrease in uncertain tax positions mean?
- Measures the net change in liabilities recognized for tax positions where the ultimate deductibility is highly uncertain or subject to audit. This metric provides insight into the company's tax risk profile and the potential for future cash outflows related to tax settlements.